Jian‐Ming Li
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 2
-
- Cancer Immunotherapy and Biomarkers 4
- Peptidase Inhibition and Analysis 3
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
-
- Ferroptosis and cancer prognosis 3
-
- Genetics and Neurodevelopmental Disorders 2
-
- Nuclear Receptors and Signaling 2
- Journals
- Oncotarget (2 papers)Cancer Biotherapy and Radiopharmaceuticals (2 papers)Cell Metabolism (1 paper)
- Partner nations
- ChinaUnited StatesRwanda
In The Last Decade
Jian‐Ming Li
20 papers receiving 685 citations
Peers
Comparison fields: 5 of 89
- Biological Psychiatry 29
- Cancer Research 166
- Oncology 209
- Immunology 152
- Molecular Biology 369
Countries citing papers authored by Jian‐Ming Li
This map shows the geographic impact of Jian‐Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Ming Li more than expected).
Fields of papers citing papers by Jian‐Ming Li
This network shows the impact of papers produced by Jian‐Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Ming Li. The network helps show where Jian‐Ming Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jian‐Ming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 23 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 1 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 39 | |
| 11 | 2021 | 73 | |
| 12 | 2021 | 19 | |
| 13 | 2021 | 118 | |
| 14 | 2020 | 27 | |
| 15 | 2020 | 16 | |
| 16 | 2020 | 102 | |
| 17 | 2017 | 28 | |
| 18 | 2015 | 29 | |
| 19 | 2015 | 8 | |
| 20 | 2009 | 118 |
About Jian‐Ming Li
Jian‐Ming Li is a scholar working on Oncology, Cancer Research, Immunology, Otorhinolaryngology and Cellular and Molecular Neuroscience, having authored 22 papers that have together received 694 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Ferroptosis and cancer prognosis (3 papers), Peptidase Inhibition and Analysis (3 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Cells and Metastasis (2 papers), Genetics and Neurodevelopmental Disorders (2 papers), Nuclear Receptors and Signaling (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Biological Psychiatry (29 citations), Cancer Research (166 citations), Oncology (209 citations), Immunology (152 citations) and Molecular Biology (369 citations). Jian‐Ming Li has collaborated with scholars based in China, United States and Rwanda. Frequent co-authors include Aijun Zhou, Jian-Ping Huo, Liheng Che, Rong Zhou, Yunxia Zhou, Wen Ni, Yuanyuan Zhao, Xiangmei Zhang, Xiu‐Ming Li and Jun Zhou. Their work appears in journals such as Oncotarget, Cancer Biotherapy and Radiopharmaceuticals, Cell Metabolism, Molecular Carcinogenesis and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.